Meryx   Report issue

For profit Phase 1
Founded: Chapel Hill NC United States (2013)

Organization Overview

First Clinical Trial
2018
NCT03510104
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Meryx, Inc.